CN: 32-1845/R
ISSN: 2095-6975
Cite this paper:
0
FENG Shu-Jun, TANG Zhi-Han, WANG Ying, TANG Xin-Ying, LI Tao-Hua, TANG Wei, KUANG Ze-Min. Potential protective effects of red yeast rice in endothelial function against atherosclerotic cardiovascular disease[J]. Chinese Journal of Natural Medicines, 2019, 17(1): 50-58

Potential protective effects of red yeast rice in endothelial function against atherosclerotic cardiovascular disease

FENG Shu-Jun1, TANG Zhi-Han2,3, WANG Ying4, TANG Xin-Ying1, LI Tao-Hua2, TANG Wei2,5, KUANG Ze-Min6
1 Department of Cardiology, The First People's Hospital of Chenzhou, University of South China, Chenzhou 423000, China;
2 Institute of Cardiovascular Disease, Key Lab for Arteriosclerology of Hunan Province, University of South China, Hengyang 421001, China;
3 Department of Biochemistry and Molecular Biology, The Libin Cardiovascular Institute of Alberta, The University of Calgary, Health Sciences Center, 3330 Hospital Drive NW, Calgary T2N 4N1, Canada;
4 Department of Cardiology, The Second Affiliated Hospital of Henan University of Science and Technology, Luoyang 471000, China;
5 Class 2014, Medical College, University of South China, Hengyang 421001, China;
6 Department of Hypertension, Beijing Anzhen Hospital of Capital Medical University, Beijing 100029, China
Abstract:
Atherosclerotic cardiovascular disease (ASCVD) is the deadliest disease in the world, with endothelial injury occurring throughout the course of the disease. Therefore, improvement in endothelial function is of essential importance in the prevention of ASCVD. Red yeast rice (RYR), a healthy traditional Chinese food, has a lipid modulation function and also plays a vital role in the improvement of endothelial reactivity and cardiovascular protection; thus, it is significant in the prevention and treatment of ASCVD. This article reviews the molecular mechanisms of RYR and its related products in the improvement of endothelial function in terms of endothelial reactivity, anti-apoptosis of endothelial progenitor cells, oxidative stress alleviation and anti-inflammation.
Key words:    Red yeast rice    Xuezhikang    Atherosclerotic cardiovascular disease    Endothelial cells    Molecular mechanism   
Received: 2018-09-20   Revised:
Tools
PDF (1721 KB) Free
Print this page
Email this article to others
Authors
Articles by FENG Shu-Jun
Articles by TANG Zhi-Han
Articles by WANG Ying
Articles by TANG Xin-Ying
Articles by LI Tao-Hua
Articles by TANG Wei
Articles by KUANG Ze-Min
References:
[1] Patel S. Functional food red yeast rice (RYR) for metabolic syndrome amelioration:a review on pros and cons[J]. World J Microbiol Biotechnol, 2016, 32(5):87.
[2] Feng Y, Xu H, Chen K. Natural polypill Xuezhikang:its clinical benefit and potential multicomponent synergistic mechanisms of action in cardiovascular disease and other chronic conditions[J]. J Altern Complement Med, 2012, 18(4):318-328.
[3] Shi YC, Pan TM. Beneficial effects of Monascus purpureus NTU 568-fermented products:a review[J]. Appl Microbiol Biot, 2011, 90(4):1207-1217.
[4] Zhou XZ, Lin SF, He SH. Research progress in pharmacodynamics evaluation of red yeast rice[J]. Mod Chin Med, 2016, 18(7):936-941.
[5] Halbert SC, French B, Gordon RY, et al. Tolerability of red yeast rice (2, 400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance[J]. Am J Cardiol, 2010, 105(2):198-204.
[6] Lin CP, Chen YH, Chen JW, et al. Cholestin (Monascus purpureus rice) inhibits homocysteine-induced reactive oxygen species generation, nuclear factor-kappaB activation, and vascular cell adhesion molecule-1 expression in human aortic endothelial cells[J]. J Biomed Sci, 2008, 15(2):183-196.
[7] Cicero AFG, Fogacci F, Bove M, et al. Short-Term effects of a combined nutraceutical on lipid level, fatty liver biomarkers, hemodynamic parameters, and estimated cardiovascular disease risk:a double-blind, placebo-controlled randomized clinical trial[J]. Adv Ther, 2017, 34(8):1966-1975.
[8] Wang LJ, Chen SX, Yang YB, et al. HPLC method for determination of monacolins in Xuezhikang Capsules[J]. Chin J Convalescent Med, 2015, 24(5):479-481.
[9] Ma J, Li Y, Ye Q, et al. Constituents of red yeast rice, a traditional Chinese food and medicine[J]. J Agric Food Chem, 2000, 48(11):5220-5225.
[10] Cicero AF, Morbini M, Rosticci M, et al. Middle-term dietary supplementation with red yeast rice plus coenzyme Q10 improves lipid pattern, endothelial reactivity and arterial stiffness in moderately hypercholesterolemic subjects[J]. Ann Nutr Metab, 2016, 68(3):213-219.
[11] Lu ZL. Collaborative group for China coronary secondary prevention using Xuezhikang, China coronary secondary prevention study (CCSPS)[J]. Chin J Cardiol, 2005, 33(2):109-115.
[12] Ye P, Lu ZL, Du BM, et al. Effect of xuezhikang on cardiovascular events and mortality in elderly patients with a history of myocardial infarction:a subgroup analysis of elderly subjects from the China coronary secondary prevention study[J]. J Am Geriatr Soc, 2007, 55(7):1015-1022.
[13] Li JJ, Lu ZL, Kou WR, et al. Beneficial impact of Xuezhikang on cardiovascular events and mortality in elderly hypertensive patients with previous myocardial infarction from the China coronary secondary prevention study (CCSPS)[J]. J Clin Pharmacol, 2009, 49(8):947-956.
[14] Yang XK, Chu YL, Chen M. Efficacy of Xuezhikang for normal cholesterol level patients with angina[J]. Chin J Trauma Disability Med, 2009, 17(4):89-90.
[15] Lu ZL, Du BM, Chen Z, et al. China coronary secondary prevention study (CCSPS):outcomes from analysis of coronary heart disease patients with diabetes[J]. Chin J Cardiol, 2005, 33(12):1067-1070.
[16] Du BM, Lu ZL, Chen Z, et al. The beneficial effects of lipid-lowering therapy with xuezhikang on cardiac events and total mortality in coronary heart disease patients with or without hypertension:a random, double-blinded, placebo controlled clinical trial[J]. Chin J Cardiol, 2006, 34(10):890-894.
[17] Lu Z, Kou W, Du B, et al. Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction[J]. Am J Cardiol, 2008, 101(12):1689-1693.
[18] Huang B. Anti-ischemic effect of Xuezhikang on acute coronary patients with different blood lipid[J]. Clin Med Eng, 2007, (6):26-27.
[19] Li JJ, Lu ZL, Kou WR, et al. Long-term effects of Xuezhikang on blood pressure in hypertensive patients with previous myocardial infarction:data from the Chinese coronary secondary prevention study (CCSPS)[J]. Clin Exp Hypertens, 2010, 32(8):491-498.
[20] Zhu ZT, Ma YX, Wang J. Effects of combined application of xuezhikang capsule with hypotensive drugs on arterial compliance and smoothness of the dynamic blood pressure[J]. Chin J Integr Trad West Med, 2010, 30(5):463-466.
[21] Gong C, Huang SL, Huang JF, et al. Effects of combined therapy of Xuezhikang Capsule and Valsartan on hypertensive left ventricular hypertrophy and heart rate turbulence[J]. Chin J Integr Med, 2010, 16(2):114-118.
[22] Sacks FM, Moye LA, Davis BR, et al. Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial[J]. Circulation, 1998, 97(15):1446-1452.
[23] Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators[J]. New Engl J Med, 1996, 335(14):1001-1009.
[24] Yang CW, Mousa SA. The effect of red yeast rice (Monascus purpureus) in dyslipidemia and other disorders[J]. Complement Ther Med, 2012, 20(6):466-474.
[25] Oelze M, Knorr M, Kroller-Schon S, et al. Chronic therapy with isosorbide-5-mononitrate causes endothelial dysfunction, oxidative stress, and a marked increase in vascular endothelin-1 expression[J]. Eur Heart J, 2013, 34(41):3206-3216.
[26] Wang WH, Zhang H, Yu YL, et al. Intervention of xuezhikang on patients of acute coronary syndrome with different levels of blood lipids[J]. Chin J Integr Trad West Med, 2004, 24(12):1073-1076.
[27] Li JJ, Wang Y, Nie SP, et al. Xuezhikang, an extract of cholestin, decreases plasma inflammatory markers and endothelin-1, improve exercise-induced ischemia and subjective feelings in patients with cardiac syndrome X[J]. Int J Cardiol Heart Vessel, 2007, 122(1):82-84.
[28] Huang YS, Wang SR, Zhi YF, et al. Effects of xuezhikang capsules on vascular endothelial function and redox status in patients with coronary heart disease[J]. J Chin Integr Med, 2006, 4(3):251-255.
[29] Spigoni V, Aldigeri R, Antonini M, et al. Effects of a new nutraceutical formulation (berberine, red yeast rice and chitosan) on Non-HDL cholesterol levels in individuals with dyslipidemia:results from a randomized, double blind, placebo-controlled Study[J]. Int J Mol Sci, 2017, 18(7):1498.
[30] Moroni L, Selmi C, Angelini C, et al. Evaluation of endothelial function by flow-mediated dilation:a comprehensive review in rheumatic disease[J]. Arch Immunol Ther Exp(Warsz), 2017, 65(6):463-475
[31] Matsuzawa Y, Kwon TG, Lennon RJ, et al. Prognostic value of flow-mediated vasodilation in brachial artery and fingertip artery for cardiovascular events:a systematic review and meta-analysis[J]. J Am Heart Assoc, 2015, 4(11):e002270.
[32] Affuso F, Ruvolo A, Micillo F, et al. Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study[J]. Nutr Metab Cardiovasc Dis, 2010, 20(9):656-661.
[33] Affuso F, Mercurio V, Ruvolo A, et al. A nutraceutical combination improves insulin sensitivity in patients with metabolic syndrome[J]. World J Cardiol, 2012, 4(3):77-83.
[34] Asmar R, Rudnichi A, Blacher J, et al. Pulse pressure and aortic pulse wave are markers of cardiovascular risk in hypertensive populations[J]. Am J Hypertens, 2001, 14(2):91-97.
[35] Cicero AF, Morbini M, Parini A, et al. Effect of red yeast rice combined with antioxidants on lipid pattern, hs-CRP level, and endothelial function in moderately hypercholesterolemic subjects[J]. Ther Clin Risk Manag, 2016, 12:281-286.
[36] Sitia S, Tomasoni L, Atzeni F, et al. From endothelial dysfunction to atherosclerosis[J]. Autoimmun Rev, 2010, 9(12):830-834.
[37] Nguyen T, Karl M, Santini A. Red Yeast Rice[J]. Foods, 2017, 6(3):E19.
[38] Lee MH, Chen SJ, Tsao CM, et al. Perivascular adipose tissue inhibits endothelial function of rat aortas via caveolin-1[J]. PLoS One, 2014, 9(6):e99947.
[39] Balakumar P, Kathuria S, Taneja G, et al. Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins?[J]. J Mol Cell Cardiol, 2012, 52(1):83-92.
[40] Zhu XY, Li P, Yang YB, et al. Xuezhikang, extract of red yeast rice, improved abnormal hemorheology, suppressed caveolin-1 and increased eNOS expression in atherosclerotic rats[J]. PloS One, 2013, 8(5):e62731.
[41] Lu L, Zhou JZ, Wang L, et al. Effects of Xuezhikang and pravastatin on circulating endothelial progenitor cells in patients with essential hypertension[J]. Chin J Integr Med, 2009, 15(4):266-271.
[42] Kong XQ, Wang MZ, Wang LX, et al. Effects of xuezhikang on proliferation and adhesion capacity of cultured endothelial progenitor cells:An in vitro study[J]. Curr Ther Res Clin Exp, 2008, 69(3):252-259.
[43] Katan MB, Grundy SM, Jones P, et al. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels[J]. Mayo Clin Proc, 2003, 78(8):965-978.
[44] Dimmeler S, Aicher A, Vasa M, et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI3-kinase/Akt pathway[J]. J Clin Invest, 2001, 108(3):391-397.
[45] Liu JT, Chen HY, Chen WC, et al. Red yeast rice protects circulating bone marrow-derived proangiogenic cells against high-glucose-induced senescence and oxidative stress:the role of heme oxygenase-1[J]. Oxid Med Cell Longev, 2017, 2017:3831750.
[46] Fan XF, Deng YQ, Ye L, et al. Effect of Xuezhikang Capsule on serum tumor necrosis factor-alpha and interleukin-6 in patients with nonalcoholic fatty liver disease and hyperlipidemia[J]. Chin J Integr Med, 2010, 16(2):119-123.
[47] Ding M, Si D, Zhang W, et al. Red yeast rice repairs kidney damage and reduces inflammatory transcription factors in rat models of hyperlipidemia[J]. Exp Ther Med, 2014, 8(6):1737-1744.
[48] Xie X, Wang Y, Zhang S, et al. Chinese red yeast rice attenuates the development of angiotensin Ⅱ-induced abdominal aortic aneurysm and atherosclerosis[J]. J Nutr Biochem, 2012, 23(6):549-556.
[49] Lin CP, Lin YL, Huang PH, et al. Inhibition of endothelial adhesion molecule expression by Monascus purpureus-fermented rice metabolites, monacolin K, ankaflavin, and monascin[J]. J Sci Food Agric, 2011, 91(10):1751-1758.
[50] Kumar S, Srivastava N, Gomes J. The effect of lovastatin on oxidative stress and antioxidant enzymes in hydrogen peroxide intoxicated rat[J]. Food Chem Toxicol, 2011, 49(4):898-902.
[51] Jeon SM, Bok SH, Jang MK, et al. Antioxidative activity of naringin and lovastatin in high cholesterol-fed rabbits[J]. Life Sci, 2001, 69(24):2855-2866.
[52] Schnabel R, Lubos E, Messow CM, et al. Selenium supplementation improves antioxidant capacity in vitro and in vivo in patients with coronary artery disease. The SElenium Therapy in Coronary Artery disease Patients (SETCAP) Study[J]. Am Heart J, 2008, 156(6):1201.e1-11.
[53] Li P, Yang Y, Liu M. Xuezhikang, extract of red yeast rice, inhibited tissue factor and hypercoagulable state through suppressing nicotinamide adenine dinucleotide phosphate oxidase and extracellular signal-regulated kinase activation[J]. J Cardiovasc Pharmacol, 2011, 58(3):307-318.
[54] Wang J, Jiang W, Zhong Y, et al. Xuezhikang attenuated the functional and morphological impairment of pancreatic islets in diabetic mice via the inhibition of oxidative stress[J]. J Cardiovasc Pharmacol, 2014, 63(3):282-289.
[55] Tien AJ, Chueh TH, Hsia CP, et al. Monascus adlay and monacolin K attenuates arterial thrombosis in rats through the inhibition of ICAM-1 and oxidative stress[J]. Kidney Blood Press Res, 2016, 41(6):815-827.
[56] Li JJ, Zhang ZY. The progress of anti-atherosclerosis of magnesium[J]. Stud Trace Elem Health (Chin), 2003, 20(2):49-51,58.
[57] Cunha AR, D'El-Rei J, Medeiros F, et al. Oral magnesium supplementation improves endothelial function and attenuates subclinical atherosclerosis in thiazide-treated hypertensive women[J]. J Hypertens, 2017, 35(1):89-97.
[58] Committee of Cardio-Cerebro-Vascular diseases of Gerontological Society of China, working group of Chinese expert consensus on the use of Xuezhikang. Chinese expert consensus on the use of Xuezhikang (2017 revised edition)[J]. Chin J Intern Med, 2018, 57(2):97-100.